BSE filing, NSE: NYKAA. Summary written from the filing by ALFA Finder's alert engine.
FSN E-Commerce Ventures Ltd: key numbers
- Share price
- ₹355.50
- Market cap
- ₹1,01,840 Cr
- Revenue (annual)
- ₹10,022 Cr
- Net profit (annual)
- ₹199.4 Cr
- P/E (TTM)
- 315.8×Sector 64.0×
- Promoter holding
- 52.07%-0.01% QoQ
- FII holding
- 15.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from FSN E-Commerce Ventures Ltd
All →FSN E-Commerce Ventures Earnings Call Transcript: Key Takeaways
Q2 FY27: revenue ₹3,006 Cr (+28%), EBITDA ₹263 Cr (+65%, 8.7% margin), PAT ₹101 Cr (+207%). Growth is real, but the festive quarter is unfinished and H1 operating cash flow is negative.
FSN E-Commerce Ventures Acquisition Worth ₹33 Cr
FSN E-Commerce (Nykaa) will acquire 82% control of Simply Nam Beauty for up to Rs.33 Crore in cash. The acquisition will be done in tranches, with completion targeted by December 2026.
- Value
- ₹33.00 Cr
- Execution
- Completion by 31-12-2026, in tranches
FSN E-Commerce Ventures Acquisition
Nykaa reported Q2 FY27 revenue up 28% YoY to Rs. 3,006 Cr with PAT up 207%. It is acquiring an 82% majority stake in Simply Nam Beauty.
FSN E-Commerce Ventures Investor Presentation: Key Takeaways
Q2FY27: net revenue Rs 3,006 Cr (+28%), EBITDA Rs 263 Cr (8.7% margin), PAT Rs 101 Cr (3.4% margin). Beauty drives profit; Fashion near breakeven.
FSN E-Commerce Ventures Q2 FY27 Results: Net Profit ₹101.2 Cr, Up 206.7% YoY
FSN E-Commerce Ventures Ltd reported revenue from operations of ₹3,006 Cr (+28.1% YoY) and net profit of ₹101.2 Cr (+206.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹101.2 Cr · +206.7% YoY
FSN E-Commerce Ventures Board Meeting Date
FSN E-Commerce (Nykaa) will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 24 September to 6 November 2026.
Other other announcement announcements
All →Mankind Pharma Other Announcement
Mankind Pharma Limited received an ESG rating of 64.8 from SES ESG Research. This rating was independently assigned for FY26 based on publicly available information.
Moneyview Other Announcement
Moneyview Ltd has appointed Ankit Kumar Jain as Nodal Officer for the Investor Education and Protection Fund. This role handles claim verification and coordination with the IEPF Authority.
Mastek Other Announcement
Mastek Limited has announced a change in the corporate office address of its Registrar and Share Transfer Agent, KFin Technologies Limited. The change is effective December 1, 2026.
Desi Farms India Other Announcement
Desi Farms India Ltd has appointed M/s Ojha Agrawal & Associates as Statutory Auditors. The appointment fills a casual vacancy following the resignation of the previous auditors.
Faze Three Other Announcement
Faze Three Ltd files its quarterly shareholding pattern as of 30 September 2026. The filing notes 2,78,840 shares allotted to its ESOP trust on 11 August 2026.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies to extend its 51st Annual General Meeting deadline. The meeting will now be held by December 31, 2026.